| |
| |
|
| Insider
Information: |
Birznieks Gunther |
| Relationship: |
|
| City: |
Washington |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
313,569 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,448,689 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
313,569 |
|
|
| Total
Value |
$1,448,689 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -116.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
|
2024-03-05 |
313,569 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2024-03-05 |
4 |
S |
$4.13 |
$35,884 |
D/D |
(8,684) |
313,569 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2024-03-04 |
4 |
S |
$4.30 |
$37,495 |
D/D |
(8,727) |
322,253 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
330,980 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2023-03-03 |
4 |
S |
$6.26 |
$51,791 |
D/D |
(8,268) |
205,980 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2023-03-02 |
4 |
S |
$6.20 |
$52,793 |
D/D |
(8,509) |
214,248 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
222,757 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2022-08-26 |
4 |
OE |
$3.12 |
$3,900 |
D/D |
1,250 |
190,057 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2022-03-02 |
4 |
S |
$11.27 |
$129,792 |
D/D |
(11,517) |
188,807 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2022-03-01 |
4 |
S |
$11.19 |
$45,700 |
D/D |
(4,084) |
200,324 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
204,408 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2021-03-02 |
4 |
S |
$18.19 |
$302,273 |
D/D |
(16,620) |
171,708 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2021-03-01 |
4 |
S |
$18.66 |
$71,744 |
D/D |
(3,845) |
188,328 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
192,173 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2020-03-03 |
4 |
S |
$10.66 |
$58,984 |
D/D |
(5,535) |
159,473 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2020-03-02 |
4 |
S |
$10.04 |
$122,686 |
D/D |
(12,223) |
165,008 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
177,231 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2020-01-02 |
4 |
S |
$15.93 |
$64,021 |
D/D |
(4,020) |
147,231 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2019-03-04 |
4 |
S |
$19.89 |
$174,767 |
D/D |
(8,788) |
151,251 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2019-03-01 |
4 |
S |
$20.14 |
$75,325 |
D/D |
(3,741) |
160,039 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
163,780 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2019-01-03 |
4 |
S |
$26.09 |
$42,232 |
D/D |
(1,619) |
133,780 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2019-01-02 |
4 |
S |
$26.30 |
$117,578 |
D/D |
(4,442) |
135,399 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2018-03-01 |
4 |
S |
$18.72 |
$159,605 |
D/D |
(8,525) |
139,841 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
148,366 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, Business Development |
• – – |
2018-01-02 |
4 |
S |
$15.26 |
$130,777 |
D/D |
(8,568) |
118,366 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
